Selected research
Industry Research
Cytotoxicity Testing Services Industry Research Report 2026
Market perspective
The global Cytotoxicity Testing Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cytotoxicity Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cytotoxicity Testing Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cytotoxicity Testing Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cytotoxicity Testing Services include Sartorius, Eurofins Scientific, TÜV SÜD, Nelson Labs, Pacific BioLabs, Emery Pharma, UFAG Laboratorien AG, NorthEast BioLab and Biosafe Ltd, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cytotoxicity Testing Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cytotoxicity Testing Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cytotoxicity Testing Services Market by Company
Sartorius
Eurofins Scientific
TÜV SÜD
Nelson Labs
Pacific BioLabs
Emery Pharma
UFAG Laboratorien AG
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
Medicilon
UL
SGS
iuvo BioScience
Cytotoxicity Testing Services Segment by Type
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others
Cytotoxicity Testing Services Segment by Application
Drug
Medical Instruments
Cosmetics and Personal Care
Others
Cytotoxicity Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cytotoxicity Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cytotoxicity Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cytotoxicity Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cytotoxicity Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Elution Testing Method
- Agar Overlay Method
- Direct Contact Method
- MTT Assay Method
- Others
Applications
- Drug
- Medical Instruments
- Cosmetics and Personal Care
- Others
Companies covered
- Sartorius
- Eurofins Scientific
- TÜV SÜD
- Nelson Labs
- Pacific BioLabs
- Emery Pharma
- UFAG Laboratorien AG
- NorthEast BioLab
- Biosafe Ltd
- Creative Bioarray
- Evercyte
- IONTOX
- Applied StemCell
- Xenometrix AG
- Medicilon
- UL
- SGS
- iuvo BioScience
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cytotoxicity Testing Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Elution Testing Method
- 2.2.3 Agar Overlay Method
- 2.2.4 Direct Contact Method
- 2.2.5 MTT Assay Method
- 2.2.6 Others
- 2.3 Cytotoxicity Testing Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug
- 2.3.3 Medical Instruments
- 2.3.4 Cosmetics and Personal Care
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Cytotoxicity Testing Services Breakdown Data by Type
- 3.1 Global Cytotoxicity Testing Services Historic Market Size by Type (2021-2026)
- 3.2 Global Cytotoxicity Testing Services Forecasted Market Size by Type (2027-2032)
4 Cytotoxicity Testing Services Breakdown Data by Application
- 4.1 Global Cytotoxicity Testing Services Historic Market Size by Application (2021-2026)
- 4.2 Global Cytotoxicity Testing Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cytotoxicity Testing Services Market Perspective (2021-2032)
- 5.2 Global Cytotoxicity Testing Services Growth Trends by Region
- 5.2.1 Global Cytotoxicity Testing Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cytotoxicity Testing Services Historic Market Size by Region (2021-2026)
- 5.2.3 Cytotoxicity Testing Services Forecasted Market Size by Region (2027-2032)
- 5.3 Cytotoxicity Testing Services Market Dynamics
- 5.3.1 Cytotoxicity Testing Services Industry Trends
- 5.3.2 Cytotoxicity Testing Services Market Drivers
- 5.3.3 Cytotoxicity Testing Services Market Challenges
- 5.3.4 Cytotoxicity Testing Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cytotoxicity Testing Services Players by Revenue
- 6.1.1 Global Top Cytotoxicity Testing Services Players by Revenue (2021-2026)
- 6.1.2 Global Cytotoxicity Testing Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Cytotoxicity Testing Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cytotoxicity Testing Services Head Office and Area Served
- 6.4 Global Cytotoxicity Testing Services Players, Product Type & Application
- 6.5 Global Cytotoxicity Testing Services Manufacturers Established Date
- 6.6 Global Cytotoxicity Testing Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cytotoxicity Testing Services Market Size (2021-2032)
- 7.2 North America Cytotoxicity Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 7.4 North America Cytotoxicity Testing Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cytotoxicity Testing Services Market Size (2021-2032)
- 8.2 Europe Cytotoxicity Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 8.4 Europe Cytotoxicity Testing Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cytotoxicity Testing Services Market Size (2021-2032)
- 9.2 Asia-Pacific Cytotoxicity Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cytotoxicity Testing Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cytotoxicity Testing Services Market Size (2021-2032)
- 10.2 South America Cytotoxicity Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 10.4 South America Cytotoxicity Testing Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cytotoxicity Testing Services Market Size (2021-2032)
- 11.2 Middle East & Africa Cytotoxicity Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cytotoxicity Testing Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sartorius
- 12.1.1 Sartorius Company Information
- 12.1.2 Sartorius Business Overview
- 12.1.3 Sartorius Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.1.4 Sartorius Cytotoxicity Testing Services Product Portfolio
- 12.1.5 Sartorius Recent Developments
- 12.2 Eurofins Scientific
- 12.2.1 Eurofins Scientific Company Information
- 12.2.2 Eurofins Scientific Business Overview
- 12.2.3 Eurofins Scientific Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.2.4 Eurofins Scientific Cytotoxicity Testing Services Product Portfolio
- 12.2.5 Eurofins Scientific Recent Developments
- 12.3 TÜV SÜD
- 12.3.1 TÜV SÜD Company Information
- 12.3.2 TÜV SÜD Business Overview
- 12.3.3 TÜV SÜD Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.3.4 TÜV SÜD Cytotoxicity Testing Services Product Portfolio
- 12.3.5 TÜV SÜD Recent Developments
- 12.4 Nelson Labs
- 12.4.1 Nelson Labs Company Information
- 12.4.2 Nelson Labs Business Overview
- 12.4.3 Nelson Labs Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.4.4 Nelson Labs Cytotoxicity Testing Services Product Portfolio
- 12.4.5 Nelson Labs Recent Developments
- 12.5 Pacific BioLabs
- 12.5.1 Pacific BioLabs Company Information
- 12.5.2 Pacific BioLabs Business Overview
- 12.5.3 Pacific BioLabs Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.5.4 Pacific BioLabs Cytotoxicity Testing Services Product Portfolio
- 12.5.5 Pacific BioLabs Recent Developments
- 12.6 Emery Pharma
- 12.6.1 Emery Pharma Company Information
- 12.6.2 Emery Pharma Business Overview
- 12.6.3 Emery Pharma Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.6.4 Emery Pharma Cytotoxicity Testing Services Product Portfolio
- 12.6.5 Emery Pharma Recent Developments
- 12.7 UFAG Laboratorien AG
- 12.7.1 UFAG Laboratorien AG Company Information
- 12.7.2 UFAG Laboratorien AG Business Overview
- 12.7.3 UFAG Laboratorien AG Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.7.4 UFAG Laboratorien AG Cytotoxicity Testing Services Product Portfolio
- 12.7.5 UFAG Laboratorien AG Recent Developments
- 12.8 NorthEast BioLab
- 12.8.1 NorthEast BioLab Company Information
- 12.8.2 NorthEast BioLab Business Overview
- 12.8.3 NorthEast BioLab Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.8.4 NorthEast BioLab Cytotoxicity Testing Services Product Portfolio
- 12.8.5 NorthEast BioLab Recent Developments
- 12.9 Biosafe Ltd
- 12.9.1 Biosafe Ltd Company Information
- 12.9.2 Biosafe Ltd Business Overview
- 12.9.3 Biosafe Ltd Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.9.4 Biosafe Ltd Cytotoxicity Testing Services Product Portfolio
- 12.9.5 Biosafe Ltd Recent Developments
- 12.10 Creative Bioarray
- 12.10.1 Creative Bioarray Company Information
- 12.10.2 Creative Bioarray Business Overview
- 12.10.3 Creative Bioarray Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.10.4 Creative Bioarray Cytotoxicity Testing Services Product Portfolio
- 12.10.5 Creative Bioarray Recent Developments
- 12.11 Evercyte
- 12.11.1 Evercyte Company Information
- 12.11.2 Evercyte Business Overview
- 12.11.3 Evercyte Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.11.4 Evercyte Cytotoxicity Testing Services Product Portfolio
- 12.11.5 Evercyte Recent Developments
- 12.12 IONTOX
- 12.12.1 IONTOX Company Information
- 12.12.2 IONTOX Business Overview
- 12.12.3 IONTOX Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.12.4 IONTOX Cytotoxicity Testing Services Product Portfolio
- 12.12.5 IONTOX Recent Developments
- 12.13 Applied StemCell
- 12.13.1 Applied StemCell Company Information
- 12.13.2 Applied StemCell Business Overview
- 12.13.3 Applied StemCell Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.13.4 Applied StemCell Cytotoxicity Testing Services Product Portfolio
- 12.13.5 Applied StemCell Recent Developments
- 12.14 Xenometrix AG
- 12.14.1 Xenometrix AG Company Information
- 12.14.2 Xenometrix AG Business Overview
- 12.14.3 Xenometrix AG Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.14.4 Xenometrix AG Cytotoxicity Testing Services Product Portfolio
- 12.14.5 Xenometrix AG Recent Developments
- 12.15 Medicilon
- 12.15.1 Medicilon Company Information
- 12.15.2 Medicilon Business Overview
- 12.15.3 Medicilon Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.15.4 Medicilon Cytotoxicity Testing Services Product Portfolio
- 12.15.5 Medicilon Recent Developments
- 12.16 UL
- 12.16.1 UL Company Information
- 12.16.2 UL Business Overview
- 12.16.3 UL Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.16.4 UL Cytotoxicity Testing Services Product Portfolio
- 12.16.5 UL Recent Developments
- 12.17 SGS
- 12.17.1 SGS Company Information
- 12.17.2 SGS Business Overview
- 12.17.3 SGS Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.17.4 SGS Cytotoxicity Testing Services Product Portfolio
- 12.17.5 SGS Recent Developments
- 12.18 iuvo BioScience
- 12.18.1 iuvo BioScience Company Information
- 12.18.2 iuvo BioScience Business Overview
- 12.18.3 iuvo BioScience Revenue in Cytotoxicity Testing Services Business (2021-2026)
- 12.18.4 iuvo BioScience Cytotoxicity Testing Services Product Portfolio
- 12.18.5 iuvo BioScience Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst